Endo Pharmaceuticals announces future FDA committee meeting
Endo Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) has informed the company that an Advisory Committee will be meeting on its supplemental new drug application for OPANA ER. Read More »